Literature DB >> 2457035

Natural murine autoantibodies and conventional antibodies exhibit similar degrees of antigenic cross-reactivity.

D M Klinman1, S Banks, A Hartman, A D Steinberg.   

Abstract

Splenic B cells from normal and autoimmune mice were transferred to MHC-compatible xid recipients. Monoclonal antibodies were secreted by the transferred B cells in splenic fragment cultures. These antibodies were evaluated for reactivity and cross-reactivity against a panel of six autoantigens and two conventional antigens using an ELISA assay. The autoantibodies and conventional antibodies produced in splenic fragment cultures by normal DBA/2 and autoimmune NZB B cells expressed similar degrees of antigenic cross-reactivity. Previous studies have demonstrated that ELISA assays of splenic fragment culture supernatants detect antibodies with affinities of 5 x 10(6) M-1 or greater. We therefore also analyzed the cross-reactivity of monoclonal antibodies derived from hybridomas. This permitted an assessment of antibodies with lower binding affinities. Cross-reactivity was detected more frequently among these hybridomas. Consistent with our earlier observations, hybridoma antibodies specific for conventional antigens exhibited cross-reactivity with a frequency similar to that of antibodies specific for autoantigens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457035      PMCID: PMC303560          DOI: 10.1172/JCI113644

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Late acquisition of a germ line antibody specificity.

Authors:  N H Sigal; P J Gearhart; J L Press; N R Klinman
Journal:  Nature       Date:  1976 Jan 1-8       Impact factor: 49.962

2.  Production of antibodies of identical idiotype but diverse immunoglobulin classes by cells derived from a single stimulated B cell.

Authors:  P J Gearhart; N H Sigal; N R Klinman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

3.  The stimulation of splenic foci in vitro.

Authors:  N R Klinman; G Aschinazi
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

Review 4.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

5.  Patterned acquisition of the antibody repertoire: diversity of the hemagglutinin-specific B-cell repertoire in neonatal BALB/c mice.

Authors:  M P Cancro; D E Wylie; W Gerhard; N R Klinman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

6.  Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization.

Authors:  B Guilbert; G Dighiero; S Avrameas
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

7.  IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts.

Authors:  P J Gearhart; N D Johnson; R Douglas; L Hood
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

8.  Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.

Authors:  K Hayakawa; R R Hardy; M Honda; L A Herzenberg; A D Steinberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Autoantibodies of various specificities encoded by genes from the VH J558 family bind to foreign antigens and share idiotopes of antibodies specific for self and foreign antigens.

Authors:  M Monestier; B Bonin; P Migliorini; H Dang; S Datta; R Kuppers; N Rose; P Maurer; N Talal; C Bona
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.

Authors:  K Hayakawa; R R Hardy; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  1 in total

1.  IgG binding of monoclonal anti-nuclear antibodies from MRL-lpr/lpr mice.

Authors:  D S Pisetsky; B S Darwin; C F Reich
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.